Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer ; volume:12 ; number:1 ; day:7 ; month:7 ; year:2022 ; pages:1-21 ; date:12.2022
Scientific reports ; 12, Heft 1 (7.7.2022), 1-21, 12.2022
- Urheber
-
Ibrahim, Sherihan Salaheldin Abdelhamid
El-Aal, Sarah A. Abd
Reda, Ahmed M.
Achy, Samar El
Shahine, Yasmine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-15551-6
- URN
-
urn:nbn:de:101:1-2022082921364542042928
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ibrahim, Sherihan Salaheldin Abdelhamid
- El-Aal, Sarah A. Abd
- Reda, Ahmed M.
- Achy, Samar El
- Shahine, Yasmine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Antineoplastic chemotherapy
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Antineoplastic chemotherapy
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Antineoplastic chemotherapy
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway